000 | 00925 a2200265 4500 | ||
---|---|---|---|
005 | 20250513042150.0 | ||
264 | 0 | _c19950615 | |
008 | 199506s 0 0 eng d | ||
022 | _a0902-0063 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCanafax, D M | |
245 | 0 | 0 |
_aMinimizing cyclosporine concentration variability to optimize transplant outcome. _h[electronic resource] |
260 |
_bClinical transplantation _cFeb 1995 |
||
300 |
_a1-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aCyclosporine _xadverse effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunosuppression Therapy |
650 | 0 | 4 | _aOrgan Transplantation |
773 | 0 |
_tClinical transplantation _gvol. 9 _gno. 1 _gp. 1-13 |
|
999 |
_c7741944 _d7741944 |